Sesame Lignans Cholesterol Meta-Analysis Evidence Table

Structured evidence table for Sesame Lignans Cholesterol Meta-Analysis, generated from 2 reusable source documents in the Migaku knowledge base.

topicclaimevidence levelcitationsource
Sesame Lignans Cholesterol Meta-AnalysisIt is often associated with hormonal imbalance, metabolic disturbances, and reproductive complications, which together contribute to an elevated risk of long-term cardiometabolic disorders.4Singnale P (2026)Role of Functional Foods and Nutraceutical Compounds in Alleviating Polycystic Ovary Syndrome: A Narrative Review.
Sesame Lignans Cholesterol Meta-AnalysisTo narratively synthesize mechanistic rationale and human clinical evidence on dietary seeds and selected nutraceuticals relevant to PCOS, with emphasis on metabolic and reproductive endpoints of interest to nutrition and obstetrics/gynecology practice.4Singnale P (2026)Role of Functional Foods and Nutraceutical Compounds in Alleviating Polycystic Ovary Syndrome: A Narrative Review.
Sesame Lignans Cholesterol Meta-AnalysisProposed "seed cycling" protocols have received attention, yet most clinical data are derived from mixed-seed supplementation studies or low-level evidence, such as case reports, and should be considered hypothesis-generating.4Singnale P (2026)Role of Functional Foods and Nutraceutical Compounds in Alleviating Polycystic Ovary Syndrome: A Narrative Review.
Sesame Lignans Cholesterol Meta-AnalysisPolycystic ovary syndrome (PCOS) represents one of the most common endocrine disorders among women of reproductive age.4Singnale P (2026)Role of Functional Foods and Nutraceutical Compounds in Alleviating Polycystic Ovary Syndrome: A Narrative Review.
Sesame Lignans Cholesterol Meta-Analysis) supplementation may offer beneficial effects in modulating various cardiometabolic risk factors, although findings from clinical trials have been inconsistent.4Kuo WH (2026)Integrative Evidence on Sesame Supplementation for Cardiometabolic Risk Factors Relevant to Retinopathy.
Sesame Lignans Cholesterol Meta-AnalysisSesame supplementation significantly reduced both systolic and diastolic blood pressure.4Kuo WH (2026)Integrative Evidence on Sesame Supplementation for Cardiometabolic Risk Factors Relevant to Retinopathy.
Sesame Lignans Cholesterol Meta-AnalysisFurther-more, sesame intake was associated with a significant reduction in liver enzyme levels, particularly alanine aminotransferase (ALT).4Kuo WH (2026)Integrative Evidence on Sesame Supplementation for Cardiometabolic Risk Factors Relevant to Retinopathy.
Sesame Lignans Cholesterol Meta-AnalysisBackground Cardiometabolic disorders, such as diabetes, hypertension, dyslipidemia, retinopathy, and non-alcoholic fatty liver disease, present significant health challenges globally.4Kuo WH (2026)Integrative Evidence on Sesame Supplementation for Cardiometabolic Risk Factors Relevant to Retinopathy.
topicSesame Lignans Cholesterol Meta-Analysis
claimIt is often associated with hormonal imbalance, metabolic disturbances, and reproductive complications, which together contribute to an elevated risk of long-term cardiometabolic disorders.
evidence level4
citationSingnale P (2026)
sourceRole of Functional Foods and Nutraceutical Compounds in Alleviating Polycystic Ovary Syndrome: A Narrative Review.
topicSesame Lignans Cholesterol Meta-Analysis
claimTo narratively synthesize mechanistic rationale and human clinical evidence on dietary seeds and selected nutraceuticals relevant to PCOS, with emphasis on metabolic and reproductive endpoints of interest to nutrition and obstetrics/gynecology practice.
evidence level4
citationSingnale P (2026)
sourceRole of Functional Foods and Nutraceutical Compounds in Alleviating Polycystic Ovary Syndrome: A Narrative Review.
topicSesame Lignans Cholesterol Meta-Analysis
claimProposed "seed cycling" protocols have received attention, yet most clinical data are derived from mixed-seed supplementation studies or low-level evidence, such as case reports, and should be considered hypothesis-generating.
evidence level4
citationSingnale P (2026)
sourceRole of Functional Foods and Nutraceutical Compounds in Alleviating Polycystic Ovary Syndrome: A Narrative Review.
topicSesame Lignans Cholesterol Meta-Analysis
claimPolycystic ovary syndrome (PCOS) represents one of the most common endocrine disorders among women of reproductive age.
evidence level4
citationSingnale P (2026)
sourceRole of Functional Foods and Nutraceutical Compounds in Alleviating Polycystic Ovary Syndrome: A Narrative Review.
topicSesame Lignans Cholesterol Meta-Analysis
claim) supplementation may offer beneficial effects in modulating various cardiometabolic risk factors, although findings from clinical trials have been inconsistent.
evidence level4
citationKuo WH (2026)
sourceIntegrative Evidence on Sesame Supplementation for Cardiometabolic Risk Factors Relevant to Retinopathy.
topicSesame Lignans Cholesterol Meta-Analysis
claimSesame supplementation significantly reduced both systolic and diastolic blood pressure.
evidence level4
citationKuo WH (2026)
sourceIntegrative Evidence on Sesame Supplementation for Cardiometabolic Risk Factors Relevant to Retinopathy.
topicSesame Lignans Cholesterol Meta-Analysis
claimFurther-more, sesame intake was associated with a significant reduction in liver enzyme levels, particularly alanine aminotransferase (ALT).
evidence level4
citationKuo WH (2026)
sourceIntegrative Evidence on Sesame Supplementation for Cardiometabolic Risk Factors Relevant to Retinopathy.
topicSesame Lignans Cholesterol Meta-Analysis
claimBackground Cardiometabolic disorders, such as diabetes, hypertension, dyslipidemia, retinopathy, and non-alcoholic fatty liver disease, present significant health challenges globally.
evidence level4
citationKuo WH (2026)
sourceIntegrative Evidence on Sesame Supplementation for Cardiometabolic Risk Factors Relevant to Retinopathy.

Source documents

  1. Role of Functional Foods and Nutraceutical Compounds in Alleviating Polycystic Ovary Syndrome: A Narrative Review.
  2. Integrative Evidence on Sesame Supplementation for Cardiometabolic Risk Factors Relevant to Retinopathy.